Chaya Mazouz

Chaya Mazouz has extensive work experience in the field of Quality, Regulatory Affairs, and Clinical Operations. Starting in 2002, they worked as a Clinical Research Manager at Pharmos until 2005. From 2005 to 2007, they served as a Clinical Research Manager at TransPharma Ltd. Chaya then moved on to become the Clinical Operations Director at Medgenics from 2007 to 2008. From 2008 to 2012, they held the role of VP Clinical and Regulatory Affairs at Pluristem Therapeutics. Following this, they worked as the Head of Quality and Regulatory Affairs at LipoCure Ltd. from 2012 to 2016. Chaya then moved on to become the VP Quality and Regulatory Affairs at Enlivex Therapeutics from 2015 to 2019. In 2019, they briefly served as the Head of Regulatory Affairs at ImmunoBrain Checkpoint, Ltd. Chaya then worked as a VP Clinical and Regulatory Affairs at Panaxia Pharmaceutical Industries from 2020 to 2020. Currently, they hold the position of VP Quality (IL) & Global Regulatory Affairs at Orgenesis Inc. since 2021. In 2019 and 2020, they also worked as an Independent Consultant.

Chaya Mazouz pursued their Master of Public Health (MPH) degree from 2016 to 2018 at The Hebrew University of Jerusalem.